2023 Archives
You are viewing archived information from 2023
| Measure Title: |
RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
|
| Report Title: |
Right-to-Try Act; Terminally Ill Patients; Investigational Drugs; Biological Products
|
| Description: |
Beginning on January 1, 2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
|
| Companion: |
SB857
|
| Package: |
None
|
| Current Referral: |
HLT, CPC, FIN
|
| Introducer(s): |
BELATTI, AMATO, GANADEN, GATES, HUSSEY-BURDICK, LAMOSAO, MARTEN, MATAYOSHI, MIZUNO, NAKASHIMA, NISHIMOTO, PERRUSO, TAKENOUCHI, TARNAS, TODD, Poepoe
|
| Act: |
|
| Sort by Date | | Status Text |
| 1/30/2023 | H | Referred to HLT, CPC, FIN, referral sheet 3 |
| 1/25/2023 | H | Introduced and Pass First Reading. |
| 1/23/2023 | H | Pending introduction. |
S = Senate |
H = House |
D = Data Systems |
$ = Appropriation measure |
ConAm = Constitutional Amendment
Some of the above items require Adobe Acrobat Reader. Please visit
Adobe's download page
for detailed instructions.
HB966
No other committee reports available at this time.
You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.
No testimony available at this time.